169 related articles for article (PubMed ID: 31043645)
1. Optimizing Measurement of Vascular Endothelial Growth Factor in Small Blood Samples of Premature Infants.
Lopez Yomayuza CC; Preissner KT; Lorenz B; Stieger K
Sci Rep; 2019 May; 9(1):6744. PubMed ID: 31043645
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
Hellgren G; Löfqvist C; Hård AL; Hansen-Pupp I; Gram M; Ley D; Smith LE; Hellström A
Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519
[TBL] [Abstract][Full Text] [Related]
4. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity.
Peirovifar A; Gharehbaghi MM; Gharabaghi PM; Sadeghi K
Singapore Med J; 2013 Dec; 54(12):709-12. PubMed ID: 24356758
[TBL] [Abstract][Full Text] [Related]
6. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
Kandasamy Y; Hartley L; Rudd D; Smith R
Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
[TBL] [Abstract][Full Text] [Related]
7. Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.
Huang CY; Lien R; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):479-487. PubMed ID: 29290015
[TBL] [Abstract][Full Text] [Related]
8. Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity.
Machalinska A; Modrzejewska M; Kotowski M; Dziedziejko V; Kucia M; Kawa M; Safranow K; Baskiewicz-Masiuk M; Modrzejewska A; Karczewicz D; Rudnicki J; Machalinski B
Arch Ophthalmol; 2010 Oct; 128(10):1311-9. PubMed ID: 20938001
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor plasma levels before and after treatment of retinopathy of prematurity with ranibizumab.
Zhou Y; Jiang Y; Bai Y; Wen J; Chen L
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):31-6. PubMed ID: 25851862
[TBL] [Abstract][Full Text] [Related]
11. Increased circulation mobilization of endothelial progenitor cells in preterm infants with retinopathy of prematurity.
Babaei H; Alibabrdel M; Asadian S; Siavashi V; Jabarpour M; Nassiri SM
J Cell Biochem; 2018 Aug; 119(8):6575-6583. PubMed ID: 29737539
[TBL] [Abstract][Full Text] [Related]
12. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.
Vinekar A; Nair AP; Sinha S; Vaidya T; Chakrabarty K; Shetty R; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):2. PubMed ID: 33646290
[TBL] [Abstract][Full Text] [Related]
13. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
Kandasamy Y; Hartley L; Rudd D; Smith R
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
[TBL] [Abstract][Full Text] [Related]
14. Immune and Inflammatory Proteins in Cord Blood as Predictive Biomarkers of Retinopathy of Prematurity in Preterm Infants.
Park YJ; Woo SJ; Kim YM; Hong S; Lee YE; Park KH
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3813-3820. PubMed ID: 31525777
[TBL] [Abstract][Full Text] [Related]
15. Platelet mass index can be a reliable marker in predicting the prognosis of retinopathy of prematurity in very preterm infants.
Korkmaz L; Baştuğ O; Özdemir A; Korkut S; Karaca Ç; Akın MA; Öztürk MA
Pediatr Neonatol; 2018 Oct; 59(5):455-463. PubMed ID: 29223489
[TBL] [Abstract][Full Text] [Related]
16. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study.
Woo SJ; Park KH; Lee SY; Ahn SJ; Ahn J; Park KH; Oh KJ; Ryu A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3434-9. PubMed ID: 23633656
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of cytokines in infants with retinopathy of prematurity.
Yu H; Yuan L; Zou Y; Peng L; Wang Y; Li T; Tang S
APMIS; 2014 Sep; 122(9):818-23. PubMed ID: 24479831
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.
Kong L; Demny AB; Sajjad A; Bhatt AR; Devaraj S
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1649-54. PubMed ID: 27054517
[TBL] [Abstract][Full Text] [Related]
19. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.
Kwinta P; Bik-Multanowski M; Mitkowska Z; Tomasik T; Pietrzyk JJ
Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1467-75. PubMed ID: 18546007
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity.
Kong L; Bhatt AR; Demny AB; Coats DK; Li A; Rahman EZ; Smith OE; Steinkuller PG
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):956-61. PubMed ID: 25613938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
